Alkaloid AD Logo

Alkaloid AD

Manufactures pharmaceuticals, cosmetics, and herbal products for professionals and consumers.

ALK | MSE

Overview

Corporate Details

ISIN(s):
MKALKA101011
LEI:
Country:
North Macedonia
Address:
Blvd. Aleksandar Makedonski 12, 1000 Skopje
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alkaloid AD is a pharmaceutical company with over eight decades of experience in the manufacturing of drugs, cosmetics, and chemical products, as well as the processing of botanical raw materials. The company's operations are structured into two primary profit centers: Pharmacy, and Chemistry, Cosmetics, and Herbal Medicine. Its product portfolio encompasses a wide range of generic drugs, with a focus on oral solid dosage forms, alongside various cosmetic and herbal products. The company also engages in pharmaceutical innovation, holding an international patent for a value-added medicine, liquid Omeprazole. Alkaloid AD serves both healthcare professionals and the general consumer market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alkaloid AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Alkaloid AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Alkaloid AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ernexa Therapeutics Inc. Logo
Developing targeted, off-the-shelf cell therapies for cancer and autoimmune diseases.
United States of America
ERNA
ERYTECH Pharma S.A. Logo
Developing phage therapies to combat antibiotic-resistant bacterial infections.
France
ERYP
Esperion Therapeutics, Inc. Logo
Develops oral ACLY inhibitors to lower high LDL-C and cardiovascular risk.
United States of America
ESPR
ESSA Pharma Inc. Logo
Develops novel small molecule drugs to treat castration-resistant prostate cancer.
United States of America
EPIX
Estrella Immunopharma, Inc. Logo
Clinical-stage biopharma developing ARTEMIS® T-cell therapies for cancer & autoimmune disease.
United States of America
ESLA
Eton Pharmaceuticals, Inc. Logo
Develops and commercializes innovative treatments for rare pediatric diseases.
United States of America
ETON
EuBiologics Co., Ltd. Logo
Develops vaccines for global public health and provides biopharmaceutical CRMO services.
South Korea
206650
EUPRAXIA PHARMACEUTICALS INC. Logo
Developing targeted, extended-release therapies for GI and musculoskeletal diseases.
United States of America
EPRX
EuroAPI Logo
Global manufacturer of APIs and CDMO services for human and animal health partners worldwide.
France
EAPI
Eurobio Scientific Logo
Develops & distributes specialty IVD tests for oncology, transplant & infectious diseases.
France
ALERS

Talk to a Data Expert

Have a question? We'll get back to you promptly.